# About CJC-1295 MD — an independent editorial reading room

> CJC-1295 MD is an independent editorial project summarizing the peer-reviewed CJC-1295 research literature. It is not a clinic. It does not sell, supply, or arrange for any product.

What this site is, what it is not, and how the editorial process works.

## What CJC-1295 MD is

CJC-1295 MD is an independent editorial project that publishes summaries of the peer-reviewed research literature on CJC-1295. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product, and we are not affiliated with any vendor, compounding pharmacy, telehealth service, or research-chemical supplier. Our work is editorial commentary on publicly available science.

The 'MD' in the domain name is editorial framing — a register the publisher occupies relative to the literature, not a claim about the site's services. The phrase is meant to suggest the way a physician might read a small research record carefully at the end of a long shift, not to imply that the site is staffed by physicians, offers consultations, or operates as a medical practice. It does none of those things.

## Editorial process

Each page on this site begins with the primary research literature — peer-reviewed papers in journals like the Journal of Clinical Endocrinology and Metabolism, Endocrinology, the American Journal of Physiology, Drug Testing and Analysis, JAMA, and Psychoneuroendocrinology, plus regulatory documents from the FDA and clinical-trial registry entries from ClinicalTrials.gov, and WADA's published Prohibited List. Where a quantitative claim appears in the body copy (a half-life value, a dose, a percent change, a year), it is sourced to a specific entry on the /references page.

We do not include forum threads, anonymous blog posts, vendor product copy, or any source that has not been peer-reviewed or formally published by a regulatory body. Where the published evidence is thin — as it is for many of the long-term safety questions readers ask about CJC-1295 — we say so explicitly rather than filling the gap with inference or speculation.

## What this site does not do

This site does not sell CJC-1295. It does not arrange for CJC-1295 to be sold. It does not recommend doses for human use. It does not connect readers with prescribers, compounding pharmacies, telehealth services, or research-chemical vendors. It does not maintain a customer list, an account system, an order form, a shopping cart, or any commercial functionality.

If you are looking for medical advice about growth hormone deficiency or any other endocrine condition, the appropriate destination is a clinician licensed in your jurisdiction. If you are looking to purchase CJC-1295, this site is not that resource — and given the current FDA regulatory record on the substance (see /research), readers should be aware that 503A compounding pharmacies cannot rely on CJC-1295 as a permitted bulk substance and that compounded preparations have been subject to Class II FDA recalls.

---

An editorial digest of peer-reviewed research — not a clinic, not a vendor, not a prescription.